Related Experiment Video
Updated: Jun 14, 2026
10:52
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
Published on: March 30, 2018
Therapeutic options in mantle cell lymphoma
1Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre.
Leukemia & Lymphoma
|February 26, 2008
Summary
Mantle cell lymphoma (MCL) is an aggressive cancer. Intensive chemotherapy and stem cell transplantation (SCT) are key for managing newly-diagnosed or relapsed MCL, with recent advances improving outcomes.
Area of Science:
- Hematology
- Oncology
- Cancer Research
Background:
- Mantle cell lymphoma (MCL) is a rare but aggressive non-Hodgkin lymphoma.
- Optimal treatment strategies are crucial for improving patient outcomes and survival rates.
Purpose of the Study:
- To review current treatment options for newly-diagnosed and relapsed mantle cell lymphoma.
- To discuss recent advancements in MCL management, including stem cell transplantation (SCT).
Main Methods:
- Literature review of existing studies and clinical trials.
- Analysis of treatment protocols and outcomes for MCL patients.
- Discussion of autologous and allogeneic stem cell transplantation in MCL.
Main Results:
- Intensive chemotherapy combined with autologous stem cell transplantation (SCT) is a standard approach for optimal progression-free survival in MCL.
- Recent advances are expanding therapeutic options and improving management strategies.
- The role of both autologous and allogeneic SCT in MCL treatment is continually evolving.
Conclusions:
- Effective management of mantle cell lymphoma requires intensive therapeutic approaches.
- Ongoing research and advancements in stem cell transplantation offer improved prospects for MCL patients.
- Personalized treatment strategies incorporating SCT are vital for optimizing patient care in MCL.
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.